uPAR is a multiligand, membrane-bound receptor expressed on immune and endothelial cells, where it regulates immune activation, cell adhesion, and tissue remodeling
membrane-bound uPAR is best known for its key role in regulating the plasminogen activation system by binding uPA, a serine protease, when bound to uPAR, it catalyzes the conversion of inactive plasminogen into active plasmin, leading to the degradation of ECM proteins like fibrin.
uPAR binds vitronectin, a major ECM component, promoting the initial attachment of cells to the matrix, as well as to various integrins
uPAR-α3β1 integrin interactions are crucial for tumor cell migration, invasion, and metastasis via activation of the MAPK/ERK pathway
while uPAR and its associated proteins do not directly bind Toll-like receptors (TLRs), they can influence TLR signaling by interacting with integrins. These indirect interactions help amplify immune responses by modulating the production of inflammatory cytokines like TNF-α, IL-6, and IL-1β.
in immune cells, uPAR is involved in immune signaling, cell migration, and chemotaxis;
in endothelial cells, it responds to injury or inflammation;
in fibroblasts, it aids in tissue repair and extracellular matrix (ECM) remodeling;
in epithelial cells, it supports tissue remodeling and repair;
in adipocytes, it contributes to metabolic dysfunction and ECM remodeling, affecting fat tissue plasticity and structure
uPAR undergoes glycosylphosphatidylinositol (GPI)-anchor cleavage and proteolytic processing to generate circulating proteins, including suPAR and the fragments D1 and D2D3
all uPAR-derived circulating proteins participate in immune signaling and integrin-mediated cell activation
the uPAR fragment D2D3 has been implicated in both kidney injury and pancreatic β-cell dysfunction
suPAR may influence renal tubular cell metabolism - in vitro studies have shown that suPAR increases ATP production, mitochondrial superoxide generation, and energetic demand in proximal tubular epithelial cells, potentially sensitizing them to injury and helping explain clinical associations with acute kidney injury (AKI)
a missense variant (rs4760) in the PLAUR gene (this gene encodes a pre-uPAR protein) is associated with increased circulating suPAR levels
minor allele frequency (MAF) of rs4760 is 16% in European-ancestry populations but 0% in African-ancestry populations
8)
bone marrow–derived immature myeloid cells, neutrophils, monocytes-macrophages and dendritic cells are considered the primary sources of suPAR during acute immune activation, making circulating suPAR a marker of systemic innate immune activity
under stable, non-acute conditions, an individual’s suPAR levels remain remarkably consistent, typically fluctuating by less than 10% over five years
cigarette smoking is a potent stimulator of circulating suPAR levels
some acute infections increase suPAR levels, particularly, RNA viral infections, including HIV and SARS-CoV-2, as well as some bacterial infections.
suPar as biomarker of overactive or dysregulated innate immune system and possible key driver of chronic kidney, metabolic and cardiovascular diseases 9)
unlike acute-phase reactants such as interleukin-6 or C-reactive protein, suPAR levels remain stable during acute illness and show minimal circadian variation
raised suPar levels have been associated with subclinical atherosclerosis, and future cardiovascular events as well as chronic kidney disease progression
10)
suPAR outperforms traditional inflammatory markers, like hsCRP and IL-6, in predicting atherosclerosis, myocardial infarction, and heart failure